GL1X · GenesisL1 explorer

MolNFT v1 · #103860 · protein

Structure of a carvoxamide compound (15) (N-[4-(isoquinolin-7-yl) pyridin-2-YL]CYCLOPROPANECARBOXAMIDE) to GSK3B

4PTE · Glycogen synthase kinase-3 beta: “Structure of a carvoxamide compound (15) (N-[4-(isoquinolin-7-yl) pyridin-2-YL]CYCLOPROPANECARBOXAMIDE) to…”. X-ray diffraction, 1 ligand (2WF), 9 pockets (best druggability 0.78). MolNFT v1 #103860…

PDB
4PTE
Type
protein
Length
688 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen synthase kinase-3 beta
EC
2.7.11.26, 2.7.11.1
UniProt
P49841
Ligands
2WF
Pockets
9 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 35% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycogen synthase kinase-3 beta (EC 2.7.11.26, 2.7.11.1)protein34135% helix, 20% strandP49841
BGlycogen synthase kinase-3 beta (EC 2.7.11.26, 2.7.11.1)protein34735% helix, 20% strandP49841

Ligands and binding sites

  • 2WF · N-[4-(isoquinolin-7-yl)pyridin-2-yl]cyclopropanecarboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19440.780.80712WF
28850.760.79672WF
3880.750.9828empty
4950.480.8123empty
5770.420.8025empty

Interfaces

1 interface between chains.

  • A–B · 1165 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • 4PTE · Structure of a carvoxamide compound (15) (N-[4-(ISOQUINOLIN-7-YL)PYRIDIN-2-YL]CYCLOPROPANE… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.